Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity: Comparison of acute corneal barrier dysfunction induced by travoprost z and travoprost

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 5, 2011, Pages 437-444

  Uematsu, Masafumi ^a   Kumagami, Takeshi ^a   Shimoda, Kenichiro ^a   Kusano, Mao ^a   Teshima, Mugen ^a   To, Hideto ^a   Kitahara, Takashi ^a   Kitaoka, Takashi ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BORIC ACID; EDETATE CALCIUM DISODIUM; MANNITOL; RICINOMACROGOL; SILVER; SILVER CHLORIDE; TRAVOPROST; TRAVOPROST Z; TROMETAMOL; UNCLASSIFIED DRUG;

ACUTE CORNEAL BARRIER DYSFUNCTION; ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; CYTOTOXICITY TEST; ELECTRIC RESISTANCE; ELECTRODE; ELECTROPHYSIOLOGY; EXPERIMENTAL RABBIT; EYE TOXICITY; MALE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TRANSEPITHELIUM ELECTRIC RESISTANCE;

ANIMALS; BENZALKONIUM COMPOUNDS; CASTOR OIL; CLOPROSTENOL; CORNEA; ELECTRIC IMPEDANCE; ELECTROPHYSIOLOGY; EXCIPIENTS; MALE; MICROSCOPY, ELECTRON, SCANNING; PRESERVATIVES, PHARMACEUTICAL; RABBITS;

EID: 80054861741     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2010.0175     Document Type: Article

References (38)

1. Norn, M.S., and Opauszki, A. Effects of ophthalmic vehicles on the stability of the precorneal film. Acta Ophthalmol.55:23-34, 1977. (Pubitemid 8032535)
2. Burgalassi, S., Chetoni, P., Monti, D., et al. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol. Lett. 122:1-8, 2001. (Pubitemid 32524053)
3. Saarinen-Savolainen, P., Järvinen, T., Araki-Sasaki, K., et al. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm. Res. 15:1275-1280, 1998. (Pubitemid 28401721)
4. Tonjum, A.M. Effects of benzalkonium chloride upon the corneal epithelium studied with scanning electron microscopy. Acta Ophthalmol.53:358-366, 1975.
5. Burstein, N.L. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest. Ophthalmol. Vis. Sci. 19:308-313, 1980. (Pubitemid 11067930)
6. Pfister, R.R., and Burstein, N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: A scanning electron microscope study. Invest. Ophthalmol.15:246-259, 1976.
7. Gasset, A.R., Ishii, Y., Kaufman, H.E., and Miller, T. Cytotoxicity of ophthalmic preservatives. Am. J. Ophthalmol.78:98-105, 1974.
8. Nakamura, T., Yamada, M., Teshima, M., et al. Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients. Biol. Pharm. Bull. 30:2360-2364, 2007. (Pubitemid 350223743)
9. Xiong, C., Chen, D., Liu, J., et al. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest. Ophthalmol. Vis. Sci. 49:1850-1856, 2008.
10. Ishibashi, T., Yokoi, N., and Kinoshita, S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J. Glaucoma 12:486-490, 2003. (Pubitemid 37494177)
11. Ishida, N., Odani-Kawabata, N., Shimazaki, A., et al. Prostanoids in the therapy of glaucoma. Cardiovasc. Drug Rev. 24:1-10, 2006. (Pubitemid 46696782)
12. Leung, E.W., Medeiros, F.A., and Weinreb, R.N. Prevalence of ocular surface disease in glaucoma patients. J. Glaucoma 17:350-355, 2008.
13. Broadway, D., Grierson, I., and Hitchings, R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br. J. Ophthalmol.77:590-596, 1993. (Pubitemid 23281461)
14. Broadway, D.C., Grierson, I., O'Brien, C., et al. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch. Ophthalmol.112:1437-1445, 1994.
15. Broadway, D.C., Grierson, I., O'Brien, C. et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch. Ophthalmol.112:1446-1454, 1994. (Pubitemid 24350507)
16. Baudouin, C. Side effects of antiglaucomatous drugs on the ocular surface. Curr. Opin. Ophthalmol.7:80-86, 1996. (Pubitemid 26268834)
17. Baudouin, C., Riancho, L., Warnet, J.M. et al. In vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprost. Invest. Ophthalmol. Vis. Sci. 48:4123-4128, 2007. (Pubitemid 351261038)
18. Uematsu, M., Kumagami, T., Kusano, M., et al. Acute corneal epithelial change after instillation of benzalkonium chloride evaluated using a newly developed in vivo corneal transepithelial electric resistance measurement method. Ophthalmic Res. 39:308-314, 2007. (Pubitemid 350242710)
19. Kusano, M., Uematsu, M., Kumagami, T., et al. Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo. Cornea 29:80-85, 2010.
20. Uematsu, M., Kumagami, T., Shimoda, K., et al. Influence of alkyl chain length of benzalkonium chloride on acute corneal epithelial toxicity. Cornea 29:1296-1301, 2010.
21. Yee, R.W., Norcom, E.G., and Zhao, X.C. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system. Adv. Ther. 23:511-519, 2006.
22. Whitson, J.T., Cavanagh, H.D., Lakshman, N. et al. Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride. Adv. Ther. 23:663-671, 2006. (Pubitemid 44955845)
23. Kahook, M.Y., and Noecker, R. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv. Ther. 25:743-751, 2008.
24. Kahook, M.Y., and Noecker, R.J. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea 27:339-343, 2008. (Pubitemid 351440870)
25. McCarey, B., and Edelhauser, H. In vivo corneal epithelial permeability following treatment with prostaglandin analoges with or without benzalkonium chloride. J. Ocul. Pharmacol. Ther. 23:445-451, 2007. (Pubitemid 350202478)
26. Suzuki, K., Saito, J., Yanai, R., et al. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog. Retin. Eye Res. 22:113-133, 2003. (Pubitemid 36246530)
27. Hornof,M., Toropainen, E., andUrtti,A.Cell culturemodels of the ocular barriers. Eur. J. Pharm. Biopharm. 60:207-225, 2005.
28. Rojanasakul, Y., Liaw, J., and Robinson, J.R. Mechanisms of action of some penetration enhancers in the cornea: Laser scanning confocal microscopic and electrophysiology studies. Int. J. Pharm. 66:131-142, 1990.
29. Rojanasakul, Y., and Robinson, J.R. Electrophysiological and ultrastructural characterization of the cornea during in vitro perfusion. Int. J. Pharm. 63:1-16, 1990. (Pubitemid 20305585)
30. Chetoni, P., Burgalassi, S., Monti, D., et al. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol. In Vitro. 17:497-504, 2003. (Pubitemid 36776791)
31. Nemoto, E., Takahashi, H., Kobayashi, D., et al. Effects of poly-L-arginine on the permeation of hydrophilic compounds through surface ocular tissues. Biol. Pharm. Bull. 29:155-160, 2006. (Pubitemid 43036714)
32. Nakashima, M., Nakamura, T., Teshima, M., et al. Breakdown evaluation of corneal epithelial barrier caused by antiallergic eyedrops using an electrophysiologic method. J. Ocul. Pharmacol. Ther. 24:43-51, 2008. (Pubitemid 351156627)
33. Mishima, S., Gasset, A., Klyce, Jr., S.D., et al. Determination of tear volume and tear flow. Invest. Ophthalmol.5:264-276, 1966.
34. Noecker, R.J., Herrygers, L.A., and Anwaruddin, R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 23:490-496, 2004. (Pubitemid 38857008)
35. Debbasch, C., De La Salle, S.B., Brignole, F., et al. Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. Invest. Ophthalmol. Vis. Sci. 43:3409-3415, 2002. (Pubitemid 35334347)
36. Civiale, C., Paladino, G., Marino, C., et al. Multilayer primary epithelial cell culture from bovine conjunctiva as a model for in vitro toxicity tests. Ophthalmic Res. 35:126-136, 2003. (Pubitemid 36506418)
37. Wysenbeek, Y.S., Loya, N., Ben Sira, I., et al. The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study. Invest. Ophthalmol. Vis. Sci. 29:194-199, 1988. (Pubitemid 18057566)
38. Iqbal, J., Kim, H.J., Yang, J.S., et al. Removal of arsenic from groundwater by micellar-enhanced ultrafiltration (MEUF).Chemosphere. 66:970-976, 2007. (Pubitemid 44792188)